Literature DB >> 2812042

Changes in residues 1 and 4 of angiotensin II affect differently its agonist and tachyphylactic properties.

S I Shimuta1, C R Nakaie, A C Paiva, P Cordopatis, D Theodoropoulos.   

Abstract

Two series of angiotensin II analogues with modifications at positions 1 or 4 of the peptide chain were studied with respect to their tachyphylactic properties and to the kinetics of relaxation of the guinea-pig ileum after a contractile response to maximally effective concentrations. Tachyphylaxis was measured by the decrease in response amplitude after three successive treatments ("tachyphylactic index") and the relaxation rate was evaluated by the time taken for the tonus to reach half of its value at the moment of agonist washout ("half relaxation time"). A correlation between tachyphylactic index and half relaxation time was found for the series of position 1 analogues, but not for the position 4 analogues. For the two series, the half relaxation times of the tachyphylactic analogues decreased from the first to the third of a series of successive treatments. Bulky substituents at position 1, which did not greatly affect the agonist activity, suppressed the tachyphylactic property. The results provide evidence that the agonist and tachyphylactic properties of angiotensin II are due to its interaction, respectively, with an agonist site and a "tachyphylaxis" site on the receptor and that the structural requirements for binding to the two sites are different.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2812042     DOI: 10.1007/bf00168515

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  Effect of tyrosine ionization upon biological activities of angiotensin II and two new peptide analogues.

Authors:  C R Nakaie; M E Oshiro; G Goissis; A C Paiva
Journal:  Biochim Biophys Acta       Date:  1977-11-25

2.  Requirements for angiotensin tachyphylaxis in smooth muscles.

Authors:  T B Paiva; M E Miyamoto; L Juliano; A C Paiva
Journal:  J Pharmacol Exp Ther       Date:  1977-08       Impact factor: 4.030

3.  The effect of pH on tachyphylaxis to angiotensin peptides in the isolated guinea pig ileum and rat uterus.

Authors:  T B Paiva; L Juliano; V L Nouailhetas; A C Paiva
Journal:  Eur J Pharmacol       Date:  1974-02       Impact factor: 4.432

4.  Angiotensin tachyphylaxis and its reversal.

Authors:  P A Khairallah; I H Page; F M Bumpus; R K Türker
Journal:  Circ Res       Date:  1966-08       Impact factor: 17.367

5.  Instrument for automated synthesis of peptides.

Authors:  R B Merrifield; J M Stewart; N Jernberg
Journal:  Anal Chem       Date:  1966-12       Impact factor: 6.986

6.  Role of the two N-terminal residues of angiotensin II in the production of tachyphylaxis.

Authors:  N Miasiro; M E Oshiro; T B Paiva; A C Paiva
Journal:  Eur J Pharmacol       Date:  1983-03-04       Impact factor: 4.432

7.  Angiotensin tachyphylaxis in the isolated rabbit aorta.

Authors:  M E Oshiro; N Miasiro; T B Paiva; A C Paiva
Journal:  Blood Vessels       Date:  1984

8.  Role of sodium ions in angiotensin tachyphylaxis in the guinea-pig ileum and taenia coli.

Authors:  T B Paiva; A C Paiva; S I Shimuta
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

9.  Studies on position 1 of angiotensin II: effects on affinity and duration of action from alkyl amide substitution.

Authors:  P Cordopatis; D Theodoropoulos; G Guillemette; E Escher
Journal:  J Med Chem       Date:  1981-02       Impact factor: 7.446

10.  Structure-desensitization relationships of angiotensin analogues in the rat isolated uterus.

Authors:  G J Moore; K J Franklin; D M Nystrom; M H Goghari
Journal:  Can J Physiol Pharmacol       Date:  1985-08       Impact factor: 2.273

View more
  1 in total

1.  Pharmacological characterization of the contractile responses to angiotensin analogues in guinea-pig isolated longitudinal muscle of small intestine.

Authors:  A B Hawcock; J C Barnes
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.